A Multicentre, Double-Blind, Placebo-Controlled, Randomized Study of Etanercept in the Treatment of Adults Patients with Active, Severe and Advanced Axial Ankylosing Spondylitis

Update Il y a 4 ans
Reference: EUCTR2006-002748-27

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the efficacy of etanercept (50 mg, once weekly) with that of placebo in patients with active, severe and advanced Ankylosis Spondylitis (as defined by the modified New York criteria) at week 12.


Inclusion criteria

  • Active, severe and advanced axial ankylosing spondylitis